AAN 2024 | Potential treatment targets for migraine

Chia-Chun, Chiang, MD, from Mayo Clinic, Rochester, MN, discusses her recent publication on potential future treatment targets for migraine. She highlights the success of CGRP-targeting therapies, with eight new medications currently available, while also expressing optimism about emerging research on molecules like PACAP, prolactin, oxytocin, and various ion channels that could lead to new migraine-specific treatments.This interview was conducted at the American Academy of Neurology (AAN) Annual Meeting 2024 in Denver, CO.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world.